OS

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  

OS
Oct 6, 2024, 16:44 | Insight
Amrubicin + irinotecan vs cisplatin + irinotecan for SCLC
Stephen V Liu shared a post on X: "Randomized phase II: 1L amrubicin + irinotecan vs…
Aug 30, 2024, 18:01 | Insight
Establishing Appropriate Intermediate Endpoints in Nonmetastatic Prostate Cancer - APCCC
APCCC shared a post on LinkedIn: "Challenges and Opportunities in Establishing Appropriate Intermediate Endpoints Reflecting Patient…
Aug 19, 2024, 10:07 | Insight
Nicolas Duployez: A 4-gene prognostic model stratified OS outcomes with VEN-AZA treatment in AML
Nicolas Duployez, Molecular Biologist at Lille University Hospital, shared on X about a recent paper…
Aug 4, 2024, 06:32 | Insight
Elad Sharon: One of my favorite recent efforts from the SWOG Cancer Research Network's DART trial - a look at linear change in tumor size
Elad Sharon, Clinical and Translational Director at Dana-Farber Cancer Institute, shared JNCI's (Journal of the…
Jul 29, 2024, 09:20 | Insight
PD-L1 and durvalumab after chemoradiation for stage III NSCLC in Netherlands Cancer Registry
Stephen Liu shared on X about a recent paper by Damhuis Ram et al. titled…
Jul 19, 2024, 14:02 | Insight
The results of the IMpassion132 trial
Elisa Agostinetto shared on X a paper by Rebecca Dent et al. titled "IMpassion132 double-blind…
Jul 12, 2024, 23:29 | Insight
Clinical Utility of Pre-surgical ctDNA Detection in Early Stage NSCLC
Biagio Ricciuti shared on X: "Clinical Utility of Pre-surgical ctDNA Detection in Early Stage NSCLC…
Jul 9, 2024, 06:35 | Blog
Rahul Banerjee: Nice analysis of Australia/New Zealand multiple myeloma with emphasis on CRAB vs SLiM
Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X: “Now in The…
Jun 30, 2024, 13:53 | Insight
Long-Term Outcomes From Prostate Cancer Active Surveillance
Avirup Guha, Director of Cardio-Oncology at Georgia Cancer Center, shared on X:       …
Jun 29, 2024, 13:39 | Insight
Myeloma Paper of the Day, June 29th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Real-world analysis of renally impaired…
Jun 19, 2024, 03:11 | Insight
Andres Rodriguez Mignola: SBRT in Oligometastatic Disease in Gynecologic Tumors - A Therapeutic Option?
Andres Rodriguez Mignola, Radiation Oncologist at Ángel Roffo Institute of Oncology, shared a post on…
Jun 4, 2024, 04:35 | Blog
Kunal Jobanputra: Largest single-centre Indian data of Intermediate/Poor risk NSGCT at ASCO24
Kunal Jobanputra, Medical Oncologist at Tata Memorial Hospital, shared a post on X: "Presented the largest…
May 16, 2024, 02:34 | Blog
Dr. Domenica Lorusso discussed the survival analysis of the PAOLA1 trial - International Journal of Gynecological Cancer
International Journal of Gynecological Cancer shared on LinkedIn: "New episode of Weekly Podcast Dr. Domenica…
May 9, 2024, 00:16 | Insight
Update CheckMate 9ER summarized by Sergio Cifuentes
Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, posted on X: “Update CheckMate 9ER - PFS:…
May 3, 2024, 20:15 | Opinion
Brendon Stiles: Great presentation from Dr. Wu on ALINA
Brendon Stiles, Professor and Chief of Thoracic Surgery and Surgical Oncology at Montefiore Health System,…
Apr 19, 2024, 18:30 | Blog
Bishal Gyawali: Questions to ask when OS has improved
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of…
Apr 8, 2024, 16:20 | Drugs
Rami Manochakian: BIG NEWS press release by AstraZeneca!
Rami Manochakian, Thoracic Medical Oncologist at Mayo Clinic, shared a post on X: “Hot Off…
All: 17 Posts: 1 - 100
Special Coverage